Mosunetuzumab

An investigational, monovalent T-cell–engaging bispecific antibody

A T-cell–engaging bispecific antibody, mosunetuzumab is designed to bind to CD3 on T cells and CD20 on B cells, inducing lysis of target B cells1,2

CD=cluster of differentiation.